Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bing Chen
Institutions:
Nanjing University of Chinese Medicine,
Nanjing Drum Tower Hospital,
State Key Laboratory of Pharmaceutical Biotechnology,
Nanjing University
Observed institutions:
Nanjing University of Chinese Medicine,
Kunming University,
Nanjing Drum Tower Hospital,
State Key Laboratory of Pharmaceutical Biotechnology,
Nanjing University
ORCID:
0000-0001-9312-1909
Observed ORCID:
0000-0001-9312-1909
OpenAlex ID:
A5042088474
PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
2021
·
Tian Xia
, Ming Liu
, et al.
·
Cell Death and Disease
·
38
PDF
TRIM34‐Mediated Ubiquitination and Degradation of HIF‐1A Regulates Glycolysis in Endothelial Cells, Inhibits Angiogenesis, and Relieves the Progression of Lung Fibrosis
2025
·
Chunyan Yang
, Qing Liu
, et al.
·
The Journal of Gene Medicine
·
4
Correction: PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
2021
·
Tian Xia
, Ming Liu
, et al.
·
Cell Death and Disease
·
3
PDF
Leveraging diverse cellular stress patterns for predicting clinical outcomes and therapeutic responses in patients with multiple myeloma
2024
·
Jiaxuan Xu
, Xiaoqing Dong
, et al.
·
Journal of Cellular and Molecular Medicine
·
2
The novel retinoid WYC-209 sensitizes multiple myeloma to carfilzomib via epigenetically upregulating ZMYND8
2026
·
Jiaxuan Xu
, Jie Yan
, et al.
·
Experimental Hematology and Oncology
PDF
Noncanonical role of KDM5C in conferring bortezomib resistance via the PERK‒Nrf2 axis in multiple myeloma
2026
·
Peifen Lu
, Wenbin Shangguan
, et al.
·
Cell Death and Disease
PDF
Show more works
View as search
Works count:
6
Citation count:
47
H-index:
3
I10-index:
1
Year
Topic
Type